Cargando…
Novel olanzapine analogues presenting a reduced H(1) receptor affinity and retained 5HT(2A)/D(2) binding affinity ratio
BACKGROUND: Olanzapine is an atypical antipsychotic drug with high clinical efficacy, but which can cause severe weight gain and metabolic disorders in treated patients. Blockade of the histamine 1 (H(1)) receptors is believed to play a crucial role in olanzapine induced weight gain, whereas the the...
Autores principales: | Jafari, Somayeh, Bouillon, Marc E, Huang, Xu-Feng, Pyne, Stephen G, Fernandez-Enright, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485633/ https://www.ncbi.nlm.nih.gov/pubmed/22726212 http://dx.doi.org/10.1186/1471-2210-12-8 |
Ejemplares similares
-
In Vivo Pharmacological Evaluations of Novel Olanzapine Analogues in Rats: A Potential New Avenue for the Treatment of Schizophrenia
por: Jafari, Somayeh, et al.
Publicado: (2013) -
High-affinity tamoxifen analogues retain extensive positional disorder when bound to calmodulin
por: Milanesi, Lilia, et al.
Publicado: (2021) -
Engineering of Bispecific Affinity Proteins with High Affinity for ERBB2 and Adaptable Binding to Albumin
por: Nilvebrant, Johan, et al.
Publicado: (2014) -
High-affinity fluorescent ligands for the 5-HT(3) receptor
por: Simonin, Jonathan, et al.
Publicado: (2012) -
FoldAffinity: binding affinities from nDSF experiments
por: Niebling, Stephan, et al.
Publicado: (2021)